Amit Verma

1.2k total citations · 1 hit paper
30 papers, 729 citations indexed

About

Amit Verma is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Amit Verma has authored 30 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Amit Verma's work include Effects of Radiation Exposure (4 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Amit Verma is often cited by papers focused on Effects of Radiation Exposure (4 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Amit Verma collaborates with scholars based in United States, India and United Kingdom. Amit Verma's co-authors include Bilikere S. Dwarakanath, Abdullah Farooque, Anant Narayan Bhatt, Rohit Mathur, Rao V. Papineni, Wendy Stock, Seema Gupta, Hanumantharao G. Raj, Virinder S. Parmar and Saurabh Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Science.

In The Last Decade

Amit Verma

29 papers receiving 702 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Technological advancements in cancer diagnostics: Improvements and limitations

2023 159 citations Bilikere S. Dwarakanath, Amit Verma et al. Cancer Reports profile →

Peers

Countries citing papers authored by Amit Verma

Since Specialization

Citations

This map shows the geographic impact of Amit Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Verma more than expected).

Fields of papers citing papers by Amit Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Verma. The network helps show where Amit Verma may publish in the future.

Co-authorship network of co-authors of Amit Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Verma. A scholar is included among the top collaborators of Amit Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Verma. Amit Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contrast-enhanced photon-counting micro-CT of tumor xenograft models 2024 ·Physics in Medicine and Biology ·(unknown), Xiaodong Guo, Amit Verma, Alena Rudkouskaya, (unknown), Xavier Intes, Ge Wang, Margarida Barroso	2
2	Fluorescence Lifetime Imaging for Quantification of Targeted Drug Delivery in Varying Tumor Microenvironments 2024 ·Advanced Science ·Amit Verma, (unknown), (unknown), (unknown), Christopher James, (unknown), Jason T. Smith, Alena Rudkouskaya, Xavier Intes, Margarida Barroso	7
3	Technological advancements in cancer diagnostics: Improvements and limitations breakdown → 2023 ·Cancer Reports ·(unknown), (unknown), Bilikere S. Dwarakanath, Amit Verma, Rao V. Papineni	159
4	Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment 2022 ·Cancer Management and Research ·(unknown), Amit Verma, Bilikere S. Dwarakanath, Rao V. Papineni	48
5	Assessment and Management of Diabetic Patients During the COVID-19 Pandemic 2021 ·Diabetes Metabolic Syndrome and Obesity ·Amit Verma, Mirza Masroor Ali Beg, (unknown), Kapil Dev, Mohammed A. Alsahli, Arshad Husain Rahmani, Yamini Goyal	7
6	Radiosensitization of calreticulin‐overexpressing human glioma cell line by the polyphenolic acetate 7, 8‐diacetoxy‐4‐methylcoumarin 2021 ·Cancer Reports ·Amit Verma, (unknown), Anant Narayan Bhatt, (unknown), Ashok K. Prasad, Virinder S. Parmar, Bilikere S. Dwarakanath	2
7	Physician Burnout: A Pandemic Uncovered by a Pandemic! 2021 ·ASA Monitor ·(unknown), (unknown), (unknown), (unknown), Amit Verma	2
8	Non-Enzymatic Protein Acetylation by 7-Acetoxy-4-Methylcoumarin: Implications in Protein Biochemistry 2020 ·Protein and Peptide Letters ·Anant Narayan Bhatt, Yogesh Rai, Amit Verma, Sanjay Pandey, (unknown), Virinder S. Parmar, Anu Arya, Ashok K. Prasad, Bilikere S. Dwarakanath	1
9	<p>T-Regulatory Cells In Tumor Progression And Therapy</p> 2019 ·Cancer Management and Research ·Amit Verma, Rohit Mathur, Abdullah Farooque, (unknown), Seema Gupta, Bilikere S. Dwarakanath	62
10	Progenitor Cell Mobilization by Gamma-tocotrienol 2016 ·Health Physics ·Vijay K. Singh, Oluseyi O. Fatanmi, Amit Verma, Victoria Newman, Stephen Y. Wise, Patricia L.P. Romaine, (unknown)	12
11	Progenitors Mobilized by Gamma-Tocotrienol as an Effective Radiation Countermeasure 2014 ·PLoS ONE ·Vijay K. Singh, Stephen Y. Wise, Oluseyi O. Fatanmi, (unknown), Patricia L.P. Romaine, Victoria Newman, Amit Verma, Thomas B. Elliott, Thomas M. Seed	30
12	Modifications of Cell Signalling and Redox Balance by Targeting Protein Acetylation Using Natural and Engineered Molecules: Implications in Cancer Therapy 2014 ·Current Topics in Medicinal Chemistry ·(unknown), Amit Verma, Anant Narayan Bhatt, Paban K. Agrawala, Hanumantharao G. Raj, Shashwat Malhotra, Ashok K. Prasad, Olivier De Wever, M.B.M. Bracke, Luciano Saso, Virinder S. Parmar, Anju Shrivastava, Bilikere S. Dwarakanath	5
13	Cytotoxic and Radio-sensitizing Effects of Polyphenolic Acetates in a Human Glioma Cell Line (BMG-1) 2014 ·Current Pharmaceutical Design ·Amit Verma, (unknown), Abdullah Farooque, Anant Narayan Bhatt, Namita Kalra, Anu Arya, Ashish Dhawan, (unknown), Hanumantharao G. Raj, Ashok K. Prasad, Virinder S. Parmar, Bilikere S. Dwarakanath	9
14	Low-dose radiation therapy of cancer: role of immune enhancement 2011 ·Expert Review of Anticancer Therapy ·Abdullah Farooque, Rohit Mathur, Amit Verma, (unknown), Anant Narayan Bhatt, Jawahar Singh Adhikari, Farhat Afrin, Saurabh Singh, Bilikere S. Dwarakanath	60
15	Calcium ionophore A23187 reveals calcium related cellular stress as “I-Bodies”: An old actor in a new role 2011 ·Cell Calcium ·Amit Verma, Anant Narayan Bhatt, Abdullah Farooque, (unknown), Saurabh Singh, Bilikere S. Dwarakanath	16
16	7, 8-diacetoxy-4-methylcoumarin induced cell death in human tumor cells is influenced by calreticulin 2010 ·Biochimie ·Amit Verma, Anant Narayan Bhatt, Abdullah Farooque, (unknown), Divya Khaitan, (unknown), Anu Arya, Ashish Dhawan, Hanumantharao G. Raj, Daman Saluja, Ashok K. Prasad, Virinder S. Parmar, Bilikere S. Dwarakanath	10
17	Targeting protein acetylation for improving cancer therapy. 2008 ·PubMed ·Bilikere S. Dwarakanath, Amit Verma, Anant Narayan Bhatt, Virinder S. Parmar, Hanumantharao G. Raj	23
18	Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implications 2003 ·Leukemia Research ·Farhad Ravandi, Amit Verma, (unknown), Kenneth Pursell	4
19	Progressive Transformation of Germinal Centers 2002 ·Acta Haematologica ·Amit Verma, Wendy Stock, (unknown), (unknown), Basil A. Bradlow, Leonidas C. Platanias	9
20	Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach 2001 ·Current Opinion in Oncology ·Amit Verma, Wendy Stock	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact